Skip to main content

Effects of Erythromycin on the Propulsive Motility of Upper Gastrointestinal Tract in Rats

  • Chapter
Biochemical Pharmacology as an Approach to Gastrointestinal Disorders
  • 137 Accesses

Abstract

The differences between the postprandial mixing or propulsion and the interdigestive motility of the gastrointestinal (GI) tract are already known. Earlier studies showed dose-dependent differences in the effects of erythromycin on interdigestive motility. The various GI side-effects (vomiting, diarrhoea) also suggest that there are different effects of erythromycin on the GI motility. The aim of our study was to examine postprandially the propulsive effects of different doses of erythromycin on the movement of intraluminal contents in the upper GI tract of the rat. The animals were fasted for 24 h before the experiments but water was given freely. The rats received 1.5 ml 1.5% methylcellulose painted with 0.05% phenol-red intragastrically (test solution). Erythromycin (E. lactobionate) was given intravenously at doses of 0.05, 0.1, 0.25, 0.5, 1.0 and 5.0 mg/kg 15 min before the administration of a test solution. The animals were sacrificed 20, 60 and 120 min after administration of methylcellulose, when the distance between the front of the painted intraluminal contents and the pylorus was measured and expressed as a percentage of the total length of small intestine. The phenol-red content in the stomach and small intestine was measured spectrophotometrically and the gastric emptying was calculated from the ratio of the measured total and intestinal phenol-red content. Our results showed that the small doses of erythromycin (0.1 and 0.25 mg/kg) accelerated gastric emptying after 20 min but did not change significantly the propulsive motility of upper small intestine; however, large doses of erythromycin (1.0 and 5.0 mg/kg) decreased gastric emptying and upper GI motility after 20 and 60 min. In summary, the prokinetic action of small doses of erythromycin was demonstrated, but its effect-time on GI motility is short and the ratio of the stimulating and inhibitory doses is 1:10.

Correspondence

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weber FH, Richards RD, McCallum RW. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol. 1993; 88: 485–90.

    PubMed  CAS  Google Scholar 

  2. Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol. 1990; 259: G355–63.

    PubMed  CAS  Google Scholar 

  3. Sarna SIC, Soergel KH, Koch TR et al. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology. 1991; 101: 1488–96.

    PubMed  CAS  Google Scholar 

  4. Sütó G, Király A, Taché Y. Interleukin 13 inhibits gastric emptying in rats: Mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology. 1994; 106: 1568–75.

    Google Scholar 

  5. Urbain JI, Vantrappen G, Janssens J, Van Cutsem E, Peeters T, De Roo M. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med. 1990; 31: 1490–3.

    PubMed  CAS  Google Scholar 

  6. Downey KM, Chaput De Saintonge DM. Gastrointestinal side effects after intravenous erythromycin lactobionate. Br J Clin Pharmacol. 1986; 21: 295–9.

    Article  PubMed  CAS  Google Scholar 

  7. Peeters TL, Depoortere I. Motilin receptor: A model for development of prokinetics. Dig Dis Sci. 1994; 39: 76–8.

    Article  Google Scholar 

  8. Ebert R, Creutzfeldt W. Hormone production: the small intestine and regulatory peptides. In: Caspary WF, ed. Structure and Function of the Small Intestine. Amsterdam: Excerpta Medica; 1987: 106–15.

    Google Scholar 

  9. Depoortere I, Peeters TL, Vantrappen G. Development of motilin receptors and of motilin-and erythromycin-induced contractility in rabbits. Gastroenterology. 1990; 99: 652–8

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Karádi, O., Bódis, B., Mózsik, G. (1997). Effects of Erythromycin on the Propulsive Motility of Upper Gastrointestinal Tract in Rats. In: Gaginella, T.S., Mózsik, G., Rainsford, K.D. (eds) Biochemical Pharmacology as an Approach to Gastrointestinal Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5390-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5390-4_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6267-1

  • Online ISBN: 978-94-011-5390-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics